Preoperative chemoradiation (CRT) with concurrent capecitabine and irinotecan in MRI-defined locally advanced rectal cancer: Relationship of histologic downstaging to long-term survival end points.

Authors:
  • SMS. Myint
    S. Myint
  • SSS. Susnerwala
    S. Susnerwala
  • MWM. Wise
    M. Wise
  • BHB. J. Haylock
    B. J. Haylock
  • MSM. P. Saunders
    M. P. Saunders
  • RNR. Neupane
    R. Neupane
  • CTC. Topham
    C. Topham
  • LSL. M. Samuel
    L. M. Samuel
  • ELE. L. Levine
    E. L. Levine

Abstract
3636 Background: There is a need to increase the efficacy of preoperative downstaging CRT in locally advanced rectal cancer. Methods: Patients (median age 62 ), with rectal adenocarcinoma without distant metastases, entered this phase I/II trial (NWCOG-2) following MRI demonstration of threatened (≤ 2 mm) or involved mesorectal fascia. Pelvic radiotherapy (RT) was given to 45 Gy in 25 daily fractions in 5 weeks with concurrent oral capecitabine continuously days 1-35 at 650 mg/m2 bd (n = 110) or 825 mg/m2 bd (n = 25) and IV irinotecan once weekly in weeks 1-4 of RT at 50 mg/m2 (n = 3), 60 mg/m2 (n = 127) or 70 mg/m2 (n = 5). Patients later underwent surgical resection with total mesorectal excision (TME). Results: Between Sept 03 and Dec 06 142 patients commenced CRT with 135 patients undergoing TME a median of 61 days post-CRT. Pretreatment MRI stage of the 135 resected patients was T2: 2 (1%), T3: 100 (74%), T4: 33 (24%), N0: 31 (23%), N1: 67 (50%) and N2: 37 (27%). Histology post resection showed downstaging for T stage in 82 (61%) patients and for N stage in 83 (80%) of 104 initial N1-2 patients. 31 patients (23%) were T0 and 123 (91%) had a negative circumferential resection margin (CRM). With median follow-up of 33 months 3 patients (2%) had a local pelvic recurrence only, 33 (24%) distant metastases only and 2 (1%) both pelvic and distant. The 3-year local recurrence-free survival (LRFS) was 97.1%, metastasis-free survival (MFS) 71.4%, disease-free survival (DFS) 63.5% and overall survival (OS) 82.8%. By univariate analysis greater histologic T stage (T0 vs. T1-2 vs. T3-4) and N stage (N0 vs. N1-2) downstaging was significantly associated with superior MFS, DFS and OS. Initial MRI T and N stage, CRM status, gender, age, operation type (anterior resection vs. AP resection) and adjuvant chemotherapy (yes vs. no) were not. However, on Cox multivariate analysis only histologic T stage remained significant for MFS (p = 0.004), DFS (p = 0.005) and OS (p = 0.005). Conclusions: In poor-risk rectal cancer this CRT regimen shows high response rates and promising long-term survival. T stage downstaging may be a useful surrogate for long-term survival.